Abstract 4371592: Long Term Air Quality and Cardiovascular Mortality in Middle Age Adults: A 25-Year Combined Analysis of CDC WONDER and EPA AQS Databases from 2000-2024

Abstract

Background: Emerging evidence suggests that air pollution is a significant but under recognized contributor to cardiovascular disease (CVD) mortality, even in middle age adults. This study evaluates the association between long term statewise air quality, as measured by median Air Quality Index (AQI) and cardiovascular mortality rates among adults aged 35–44 years across the United States over a 25-year period. Methods: We linked annual statewise median AQI data from EPA AQS (2000–2024) with CDC WONDER mortality records for non-infectious CVD in the 35–44 age group. States were ranked by mean AQI to define “Highest 10” and “Lowest 10” AQI cohorts. Mean annual cardiovascular crude death rates were compared between these groups using t-tests, and trends were visualized year-by-year. Correlation and linear regression analyses assessed the association between AQI and mortality across all state years as well. Results: States with the highest long-term AQI (poor air quality) had significantly higher mean cardiovascular mortality rates (mean 46.99 per 100,000) than states with the lowest AQI (good air quality) (mean 30.35 per 100,000; p = 0.01). Yearwise analysis showed a persistent gap in mortality rates with the highest AQI states consistently exhibiting greater CVD mortality across the study period. Linear regression confirmed a significant positive association between AQI and mortality (slope = 0.62, p < 0.001), although AQI alone explained only a modest portion of the variation (R 2 = 0.095). Conclusions: Higher long term air pollution exposure, as measured by AQI, is associated with increased cardiovascular mortality among U.S. adults aged 35–44 years. This relationship is robust at the extremes of air quality and persists over time. This highlights the need for public health policies to improve air quality as a means to reduce early onset CVD mortality. Further studies should explore mechanisms and policy interventions to mitigate this risk.